Wacker expands cyclodextrin capacity
Wacker has brought its expanded cyclodextrin facility online following its $21m (€15m) expansion, which has significantly increased capacity in response to growing demand for the excipient.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs